View Older Stories View More Recent Stories

Mar 9, 2020 04:54PM Form SC 13D Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Mar 5, 2020 06:34PM Form 4 Inspire Medical Systems, For: Mar 03 Filed by: ORBIMED ADVISORS LLC
Mar 5, 2020 06:03AM Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
Mar 4, 2020 04:22PM Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 27, 2020 08:10PM Form 3 Passage BIO, Inc. For: Feb 27 Filed by: ORBIMED ADVISORS LLC
Feb 26, 2020 04:42PM Natera (NTRA) Tops Q4 EPS by 9c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus
Feb 26, 2020 04:10PM Natera Reports Fourth Quarter and Year 2019 Financial Results
Feb 19, 2020 07:05AM Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts for the 2020 Digestive Disease Week (DDW) Conference
Feb 18, 2020 09:16AM Form SC 13G Krystal Biotech, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 18, 2020 06:30AM Innovate Biopharmaceuticals Announces Shareholder Approval of All Proposals in Connection with the Pending Merger with RDD Pharma Ltd. to Create 9 Meters Biopharma, a GI-focused Platform Company
Feb 14, 2020 06:00PM Form SC 13G/A Deciphera Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 05:51PM Form SC 13G/A eHealth, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 05:40PM Form SC 13G MeiraGTx Holdings plc Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 05:34PM Form SC 13G Applied Therapeutics Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 05:28PM Form SC 13G Krystal Biotech, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 05:25PM Form SC 13G/A ARVINAS, INC. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 04:41PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 14, 2020 12:01PM Form SC 13G/A Inspire Medical Systems, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 12:01PM Form SC 13G/A Clovis Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 12:01PM Form SC 13G/A Aeglea BioTherapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 12:01PM Form SC 13G Prothena Corp plc Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 12:01PM Form SC 13G/A PUMA BIOTECHNOLOGY, INC. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 12:01PM Form SC 13G Adverum Biotechnologies, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2020 12:01PM Form SC 13G Crinetics Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Feb 10, 2020 04:40PM Form SC 13D Arcutis Biotherapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 7, 2020 05:06PM Form 4 Xtant Medical Holdings, For: Feb 05 Filed by: ORBIMED ADVISORS LLC
Feb 5, 2020 04:40PM Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 5, 2020 04:37PM Form SC 13D/A SELECTA BIOSCIENCES INC Filed by: ORBIMED ADVISORS LLC
Jan 29, 2020 04:33PM MRI Interventions, Inc. Closes $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management
Jan 28, 2020 07:30AM Bloom Burton & Co. Announces the 2020 Bloom Burton Award Gala
Jan 28, 2020 07:00AM Ikena Oncology Announces Dosing of First Patient in Phase 1 Study Evaluating IK-175 in Patients with Advanced Solid Tumors
Jan 27, 2020 08:00AM Harmony Biosciences Secures $200 Million Debt Facility
Jan 22, 2020 08:38AM PlacementTracker Publishes 2019 PIPE and Private Placement Markets League Tables
Jan 17, 2020 08:00AM Foamix Announces OrbiMed’s Support of Merger with Menlo Therapeutics
Jan 16, 2020 01:48PM OrbiMed Supports the Proposed Foamix Pharmaceuticals Ltd. And Menlo Therapeutics Inc. Merger
Jan 15, 2020 06:00AM Emendo Biotherapeutics Raises $61 Million to Advance Next Generation Genome Editing Therapeutics
Jan 13, 2020 04:47PM Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 13, 2020 08:17AM Mri Interventions, Inc. (MRIC) Obtains $17.5 Million Strategic Investment from PTC Therapeutics (PTCT) and Petrichor Healthcare Capital Management
Jan 13, 2020 08:05AM MRI Interventions, Inc. Obtains a $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management
Jan 13, 2020 08:00AM Allergan and Avitide Expand Partnership to Develop Custom Affinity Chromatography Technologies
Jan 6, 2020 08:32AM Sonendo® Announces Growth Investment from EW Healthcare Partners
Dec 26, 2019 04:02PM Form SC 13D/A Nabriva Therapeutics Filed by: ORBIMED ADVISORS LLC
Dec 19, 2019 04:39PM Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 13, 2019 04:32PM Form SC 13G/A Principia Biopharma Inc. Filed by: ORBIMED ADVISORS LLC
Dec 12, 2019 05:20PM Form SC 13D/A Tricida, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 12, 2019 05:20PM Form 4 Tricida, Inc. For: Dec 11 Filed by: ORBIMED ADVISORS LLC
Dec 11, 2019 08:00AM PMV Pharma Appoints Leila Alland, M.D., as Chief Medical Officer
Dec 9, 2019 08:00AM Gemini Therapeutics and Avitide Enter Into Exclusive License Agreement
Dec 6, 2019 04:47PM Form SC 13D/A Nabriva Therapeutics Filed by: ORBIMED ADVISORS LLC
Dec 3, 2019 07:00AM Kyn Therapeutics Rebrands as Ikena Oncology, Reflecting Next Phase of Growth
View More Recent Stories View Older Stories